Novus Biologicals全國總代

美國Novus Biologicals公司是一家抗體專業(yè)公司，生產(chǎn)用于研究的單克隆和多克隆抗體，包含5萬多種一抗和近1000種二抗，產(chǎn)品涉及神經(jīng)生物學(xué)，細(xì)胞凋亡，腫瘤，DNA修復(fù)，干細(xì)胞標(biāo)記，信號轉(zhuǎn)導(dǎo)等多個研究方向。多年的抗體生產(chǎn)服務(wù)經(jīng)驗，使novus得以生物科學(xué)發(fā)展趨勢，并可隨時為生物科研工作者提供和廣泛的產(chǎn)品。Novus的愿景是通過開發(fā)和銷售在前沿科學(xué)的*產(chǎn)品來推動科學(xué)發(fā)現(xiàn)。Novus組織了商業(yè)化機制，致力于為生物研究界提供*的生物材料。Novus還持續(xù)關(guān)注科學(xué)趨勢，并為新的研究提供必要的材料。Novus的產(chǎn)品廣泛使用于機構(gòu)和商業(yè)研究，并在推動生物學(xué)研究中起著重要的。

 

Novus Biologicals is a biotech company based in Littleton, Colorado, USA with offices in San Diego, California, Oakville, ON, Canada and the Cambridge Science Park in Cambridge, UK.[1] The company develops, licenses and markets research materials to scientists in academic, corporate and government laboratories. Novus, like many others companies such as Abcam, Covance, Proteintech Group, EnCor Biotechnology and Millipore Corporation, arose to answer a call for research grade antibodies for the scientific market.Founded by Karen Padgett in 1996, Novus Biologicals has sought to partner with leading scientific researchers and third-party providers to develop an extensive range of more than 180,000 products.[2] The main products are antibodies, proteins, peptides, RNAi, cell lysates, isotype controls, slides, and kits. Padgett is company president and CEO, and has been active both in the academic and local Colorado communities.